NCT03362723 2019-06-19A Study to Investigate the Bioequivalence or Relative Bioavailability of Three New Idasanutlin Tablet Variants Following Oral Administration in Participants With Solid TumorsHoffmann-La RochePhase 1 Completed48 enrolled